BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Medical has received approval from the U.S. Food and Drug Administration (FDA) to begin its three-center US Phase I clinical trial designed to evaluate the Cook Zenith® Dissection Endovascular System for the treatment of Type B thoracic aortic dissections. The groundbreaking trial is being conducted at Thomas Jefferson University in Philadelphia, Penn.; the University of Florida in Gainesville, Fla.; and Massachusetts General Hospital in Boston, Mass.
